Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography | Zendy

Roshan M. Patel | Zendy; Abed Janoudi | Zendy; Ameeth Vedre | Zendy; Kusai Aziz | Zendy; Umesh Tamhane | Zendy; Jack Rubinstein | Zendy; Oliver G. Abela | Zendy; Kevin L. Berger | Zendy; George S. Abela | Zendy

Open Access

Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography

Author(s) -

Roshan M. Patel,

Abed Janoudi,

Ameeth Vedre,

Kusai Aziz,

Umesh Tamhane,

Jack Rubinstein,

Oliver G. Abela,

Kevin L. Berger,

George S. Abela

Publication year - 2011

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.111.226167

Subject(s) - ezetimibe , cholesterol , inflammation , thrombus , fluorodeoxyglucose , positron emission tomography , thrombosis , medicine , pathology , nuclear medicine

This study evaluated effects of lipid lowering with ezetimibe on plaque burden and associated cholesterol crystallization and inflammation in a rabbit model of plaque disruption and thrombosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research